Perampanel and Microgynon-30 + Perampanel and Microgynon-30
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Partial Onset Epilepsy
Conditions
Partial Onset Epilepsy
Trial Timeline
Mar 1, 2010 → Oct 1, 2010
NCT ID
NCT01209858About Perampanel and Microgynon-30 + Perampanel and Microgynon-30
Perampanel and Microgynon-30 + Perampanel and Microgynon-30 is a phase 1 stage product being developed by Eisai for Partial Onset Epilepsy. The current trial status is completed. This product is registered under clinical trial identifier NCT01209858. Target conditions include Partial Onset Epilepsy.
What happened to similar drugs?
18 of 20 similar drugs in Partial Onset Epilepsy were approved
Approved (18) Terminated (5) Active (2)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01209858 | Phase 1 | Completed |
Competing Products
20 competing products in Partial Onset Epilepsy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| E2007 | Eisai | Phase 3 | 40 |
| Perampanel | Eisai | Pre-clinical | 26 |
| perampanel + perampanel | Eisai | Phase 1 | 29 |
| perampanel + perampanel + perampanel + Placebo | Eisai | Phase 3 | 40 |
| Perampanel + Placebo | Eisai | Approved | 35 |
| perampanel | Eisai | Phase 2 | 35 |
| Perampanel | Eisai | Pre-clinical | 26 |
| Zonisamide + Placebo | Eisai | Phase 3 | 40 |
| zonisamide | Eisai | Pre-clinical | 26 |
| E2007 (perampanel) + E2007 (perampanel) + Placebo | Eisai | Phase 3 | 40 |
| Perampanel + Placebo | Eisai | Phase 3 | 40 |
| E2007 (perampanel) + E2007 (perampanel) + Placebo | Eisai | Phase 3 | 40 |
| Adjunctive Zonisamide + Replacement with Zonisamide | Eisai | Approved | 43 |
| Fycompa | Eisai | Pre-clinical | 26 |
| Zonisamide + Placebo | Eisai | Phase 3 | 40 |
| Fycompa | Eisai | Pre-clinical | 26 |
| Rufinamide | Eisai | Phase 3 | 32 |
| Zonisamide | Eisai | Phase 3 | 40 |
| Eslicarbazepine Acetate tablets | Eisai | Pre-clinical | 26 |
| Perampanel | Eisai | Pre-clinical | 26 |